Analyst ratings
Across 9 analysts the consensus is a Strong Buy: 8 buy calls against 0 sell, with an average 12-month price target of $10.50.
AbCellera Biologics · NASDAQ: ABCL · Biotechnology
Over the past week, AbCellera Biologics (ABCL) pulled in about 88 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 36% bullish but is far apart: X runs 58% bullish while News sits at just 0%. Wall Street is more constructive, with 8 of 9 analysts rating ABCL a buy.
There is little buzz around ABCL this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 89% buy share sits next to a crowd that ranges from News at 0% to X at 58%. No other tracker puts the two side by side.
Across 9 analysts the consensus is a Strong Buy: 8 buy calls against 0 sell, with an average 12-month price target of $10.50.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 53 points above the crowd average of 36%, the professionals are more constructive than retail. The split is inside the crowd: X reads 58% bullish while News sits at 0%, a 58-point spread that single-source trackers miss.
Over the 30-day window, AbCellera Biologics (ABCL) buzz held elevated around 66.5 while the price drifted up 29.3% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 8.3M shares. Updated Jul 13, 2026. Over the last 7 trading days, ABCL lost 10.5%. Buzz activity in the recent week averaged 53.1 and was variable, swinging between 40.8 and 67.4. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 18 of the 18 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for ABCL and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABCL sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 13, 2026.
Based on aggregated sentiment from Reddit, X and News sources, AbCellera Biologics (ABCL) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 36% bullish across 3 active sources. Those sources contribute 88 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around AbCellera Biologics (ABCL) is fairly quiet with 4 mentions across 9 tracked subreddits. The tone is 50% bullish with stable 3-day activity momentum, suggesting steady attention.
AbCellera Biologics (ABCL) sentiment is bearish across all 3 tracked sources. Reddit reads 50% bullish, X reads 58% bullish and news coverage is the most negative at 0% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
Social sentiment data shows consistently bearish discussion around AbCellera Biologics (ABCL). All 3 tracked sources lean negative, with news being the most bearish at 0% bullish. 3-day activity momentum is rising across X. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 82 mentions (93% of total volume). Reddit contributes 4 mentions and News contributes 2 mentions. Sentiment is bearish across all sources, while x is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABCL's sell signal at 93/100 conviction reflects consistently bearish sentiment across multiple platforms. It is a research shortcut, not financial advice.
The ABCL sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to AbCellera Biologics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry sell signals, pointing to broad bearish pressure rather than an ABCL-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key